对3-基-3-甲基酸辅酶A减少酶的竞争性抑制的设计
Valeriy V Pak1, Shomansur Sh Sagdullaev1, Aleksandr V Pak2
1Laboratory of the Physical and Chemical Methods of Analysis, Institute of the Chemistry of Plant Substances, Building 77, Mirzo Ulugbek Str., 100170, Tashkent, Uzbekistan.
Biochimie
|November 3, 2025
概括
食物衍生的具有降低胆固醇的潜力,可以作为他类药物的天然替代品. 研究表明,这些可以抑制与他类药物相同的酶,为预防高胆固醇血症提供了一条新的途径.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 营养保健品 营养保健品
背景情况:
- 类药物是高胆固醇血症的已知治疗方法,它们作为3 - 基-3 - 甲基酸 - 同酶A减少酶 (HMGR) 的竞争性抑制剂.
- HMGR是胆固醇生物合成中的速度限制酶.
- 食物衍生的具有生物活性,包括有可能调节胆固醇水平.
研究的目的:
- 为了探索食品衍生的类作为HMGR抑制剂.
- 通过建模审查增强活性的方法.
- 评估在预防高胆固醇血症方面的潜力.
主要方法:
- 对食品衍生和HMGR抑制现有研究的审查.
- 对的物理化学特性进行分析,以指导建模.
- 计算和实验方法用于体设计和活动增强.
主要成果:
- 36种来自食物的被证实是具有竞争力的HMGR抑制剂.
- 最活跃的天然的IC50为12.8μM.
- 与天然对应物相比,设计的活性增加了多达700倍.
结论:
- 食物衍生的代表了一个有前途的类型的HMGR抑制剂.
- 类建模可以显著增强抑制活性.
- 类具有开发新型营养品或用于高胆固醇血症管理的药物的潜力.
相关概念视频
Enzyme Inhibition
91.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Dipeptidyl Peptidase 4 Inhibitors
574
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
574
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
898
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
898
Feedback Inhibition
56.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.8K


